Lips MA, van Klinken JB, Pijl H, Janssen I, van Dijk KW, Koning F, et al
That said, Novo Nordisk and Eli Lilly aren't exactly sitting around doing nothing, so more GLP-1 developments are likely from this pair, as well
Your Health Magazine Sponsored Reviews More Reviews Articles Shed GLP-1 Reviews 2026 How It Works, What It Costs, and Who It Is For The following information is compiled from the internet to help people find the healthcare they need
Spending on glucagon-like peptide-1 receptor agonists among US adults, JAMA Network Open (2025) H.R.4818 treat and reduce obesity act of 2023, Congress.gov (2023) Anti-obesity drugs will not be covered by Medicare and Medicaid in 2026, American College of Gastroenterology (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice